Milad Shirvaliloo

iran university of medical sciences

H指数:19

被引数:1,052

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Exploring the Impact of Nanotherapeutics on Histone H3 and H4 Acetylation Enrichment in Cancer Epigenome: A Systematic Scoping Synthesis

探索纳米治疗剂对癌症表观基因组组蛋白H3和H4乙酰化富集的影响：一项系统扫描综合研究

Epigenomes

IF3.5

2025-11-070

PRE

Synthesis, characterization, and evaluation of copper-doped zinc oxide nanoparticles anticancer effects: in vitro and in vivo experiments

BMC CANCER

IF3.4

2025-01-080

OAAI

Percutaneous Coronary Intervention Associated with a Higher Risk of Hypoxemia and COVID-19 Severity

CURRENT MEDICINAL CHEMISTRY

IF3.5

2024-03-011

PRE

Dual-drug delivery by thermo-responsive Janus nanogel for improved cellular uptake, sustained release, and combination chemo-thermal therapy

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-03-015

PRE

Application of nanotechnology in removing laboratory contaminants from the environment

TOXIN REVIEWS

IF2.4

2024-02-120

PRE

Unveiling Mesenchymal Stem Cells' Regenerative Potential in Clinical Applications: Insights in miRNA and lncRNA Implications

CELLS

IF5.2

2023-10-311

OAAI

The future opportunities and remaining challenges in the application of nanoparticle-mediated hyperthermia combined with chemo-radiotherapy in cancer

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY

IF8.2

2023-10-0111

PRE

Dynamic alterations in white blood cell counts and SARS-CoV-2 shedding in saliva: an infection predictor parameter

FRONTIERS IN MEDICINE

IF3

2023-06-154

OAAI

Epigenetic memory in breast cancer: electrochemical biosensor-based tracing of histone H3 acetylation inheritance

乳腺癌的表观遗传记忆: 基于电化学生物传感器的组蛋白H3乙酰化遗传示踪

EPIGENOMICS

IF2.6

2023-04-051

PRE

Epigenetic cues regulating airway development in human lung organoids: Polycomb repressive complex 2 and altered chromatin accessibility determine cell fate

调节人肺类器官气道发育的表观遗传线索: 多梳抑制复合物2和改变的染色质可及性决定细胞命运

FASEB JOURNAL

IF4.2

2023-03-241

PRE

LncRNA H19 promotes tumor angiogenesis in smokers by targeting anti-angiogenic miRNAs

EPIGENOMICS

IF2.6

2023-02-1912

PRE

The landscape of histone modifications in epigenomics since 2020

表观基因组学2020年中组蛋白修饰的景观

EPIGENOMICS

IF2.6

2023-01-3015

PRE

Development and classification of RNA aptamers for therapeutic purposes: an updated review with emphasis on cancer

用于治疗目的的RNA适体的开发和分类: 以癌症为重点的最新综述

MOLECULAR AND CELLULAR BIOCHEMISTRY

IF3.7

2022-11-2429

PRE

Diagnostic accuracy of clinically applied nanoparticle-based biosensors at detecting SARS-CoV-2 RNA and surface proteins in pharyngeal swabs compared to RT-PCR as a reference test

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2022-10-191

The potential use of mesenchymal stem cells and their exosomes in Parkinson's disease treatment

间充质干细胞及其外泌体在帕金森病治疗中的潜在应用

STEM CELL RESEARCH & THERAPY

IF7.3

2022-07-2846

OAAI

Cluster of differentiation frequency on antigen presenting-cells: The next step to cervical cancer prognosis?

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-07-014

PRE

SARS-CoV-2 and influenza viruses: Strategies to cope with coinfection and bioinformatics perspective

CELL BIOLOGY INTERNATIONAL

IF3.1

2022-04-0212

The unfavorable clinical outcome of COVID-19 in smokers is mediated by H3K4me3, H3K9me3 and H3K27me3 histone marks

EPIGENOMICS

IF2.6

2022-01-1312

OAAI

Novel Insight Into the Association Between Obesity and Hepatocellular Carcinoma Occurrence and Recurrence: High-Throughput Microarray Data Set Analysis of Differentially Expressed Genes

JCO CLINICAL CANCER INFORMATICS

IF2.8

2021-12-013

PRE

An Updated Review on Implications of Autophagy and Apoptosis in Tumorigenesis: Possible Alterations in Autophagy through Engineered Nanomaterials and Their Importance in Cancer Therapy

MOLECULAR PHARMACOLOGY

IF3

2021-08-0115

OAAI

Milad Shirvaliloo

个人简介

教育背景

工作经历

荣誉奖项

研究方向